XD凯赛生: 独立董事提名人声明与承诺（吴向阳）

Core Viewpoint - The nomination of Ms. Wu Xiangyang as an independent director candidate for the third board of Shanghai Kaisa Biotechnology Co., Ltd. has been made, with the nominator confirming her qualifications and independence [1][5]. Summary by Sections Nomination and Qualifications - The nominator has fully understood the nominee's professional background, education, titles, work experience, and any significant dishonesty records [1]. - The nominee possesses basic knowledge of listed company operations and has over five years of relevant work experience in law, economics, accounting, finance, or management [1]. Compliance with Regulations - The nominee meets the requirements set forth by the Company Law of the People's Republic of China and the relevant regulations from the China Securities Regulatory Commission and the Shanghai Stock Exchange [1]. - The nominee has undergone training and obtained certification recognized by the stock exchange [1]. Independence Criteria - The nominee does not fall under any categories that would compromise her independence, such as holding significant shares or having close relationships with major shareholders [2]. - The nominee has no adverse records, including administrative or criminal penalties from the China Securities Regulatory Commission in the last 36 months [3][4]. Additional Qualifications - The nominee has not been dismissed from previous independent director roles due to attendance issues and has not served as an independent director in more than three domestic listed companies [4]. - The nominee possesses substantial accounting knowledge and experience, holding qualifications such as a certified public accountant or a senior title in accounting, auditing, or financial management [4]. Verification and Assurance - The nominator has verified the nominee's qualifications according to the self-regulatory guidelines of the Shanghai Stock Exchange and guarantees the truthfulness and completeness of the statements made [5].